
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025

2148 MRD Study reaches milestone with First Patient In (FPI)
4 Aug 2025

EORTC in the spotlight at ASCO 2025
4 Jun 2025

EORTC’s presence at ASCO 2025
28 May 2025

New study confirms link between cancer patients’ quality of life and survival
1 Apr 2025

New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024

EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023

New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023